Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN320080 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-V-Myc Myelocytomatosis Viral Oncogene Homolog (Avian) (MYC) (C-Term) antibody (PE)
- Antibody type
- Monoclonal
- Antigen
- Synthetic peptide sequence AEEQKLISEEDLL corresponding to the C-terminal region of Human c-myc. Remarks: Spleen cells from immunised Balb/c mice were fused with cells of the myeloma cell line.
- Description
- Affinity Chromatography on Protein G
- Reactivity
- Human
- Host
- Mouse
- Conjugate
- Yellow dye
- Antigen sequence
EQKLISEEDL
- Epitope
- C-Term
- Isotype
- IgG
- Antibody clone number
- 9-00E-010
- Vial size
- 100 tests
- Concentration
- 0.1 mg/mL
- Storage
- Store the antibody prior to reconstitution at -20°C. Following reconstitution the antibody can be stored at 2-8°C for one month or at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Display of wasp venom allergens on the cell surface of Saccharomyces cerevisiae.
Cdc42 regulates apical junction formation in human bronchial epithelial cells through PAK4 and Par6B.
Identification of a novel human MD-2 splice variant that negatively regulates Lipopolysaccharide-induced TLR4 signaling.
Antagonistic anti-urokinase plasminogen activator receptor (uPAR) antibodies significantly inhibit uPAR-mediated cellular signaling and migration.
Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells.
The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops.
Co-operative Cdc42 and Rho signalling mediates ephrinB-triggered endothelial cell retraction.
Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression.
Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.
Borodina I, Jensen BM, Søndergaard I, Poulsen LK
Microbial cell factories 2010 Sep 24;9:74
Microbial cell factories 2010 Sep 24;9:74
Cdc42 regulates apical junction formation in human bronchial epithelial cells through PAK4 and Par6B.
Wallace SW, Durgan J, Jin D, Hall A
Molecular biology of the cell 2010 Sep 1;21(17):2996-3006
Molecular biology of the cell 2010 Sep 1;21(17):2996-3006
Identification of a novel human MD-2 splice variant that negatively regulates Lipopolysaccharide-induced TLR4 signaling.
Gray P, Michelsen KS, Sirois CM, Lowe E, Shimada K, Crother TR, Chen S, Brikos C, Bulut Y, Latz E, Underhill D, Arditi M
Journal of immunology (Baltimore, Md. : 1950) 2010 Jun 1;184(11):6359-66
Journal of immunology (Baltimore, Md. : 1950) 2010 Jun 1;184(11):6359-66
Antagonistic anti-urokinase plasminogen activator receptor (uPAR) antibodies significantly inhibit uPAR-mediated cellular signaling and migration.
Duriseti S, Goetz DH, Hostetter DR, LeBeau AM, Wei Y, Craik CS
The Journal of biological chemistry 2010 Aug 27;285(35):26878-88
The Journal of biological chemistry 2010 Aug 27;285(35):26878-88
Inducible proteolytic inactivation of OPA1 mediated by the OMA1 protease in mammalian cells.
Head B, Griparic L, Amiri M, Gandre-Babbe S, van der Bliek AM
The Journal of cell biology 2009 Dec 28;187(7):959-66
The Journal of cell biology 2009 Dec 28;187(7):959-66
The structure of the anti-c-myc antibody 9E10 Fab fragment/epitope peptide complex reveals a novel binding mode dominated by the heavy chain hypervariable loops.
Krauss N, Wessner H, Welfle K, Welfle H, Scholz C, Seifert M, Zubow K, Aÿ J, Hahn M, Scheerer P, Skerra A, Höhne W
Proteins 2008 Nov 15;73(3):552-65
Proteins 2008 Nov 15;73(3):552-65
Co-operative Cdc42 and Rho signalling mediates ephrinB-triggered endothelial cell retraction.
Groeger G, Nobes CD
The Biochemical journal 2007 May 15;404(1):23-9
The Biochemical journal 2007 May 15;404(1):23-9
Creation of tolerogenic human dendritic cells via intracellular CTLA4: a novel strategy with potential in clinical immunosuppression.
Tan PH, Yates JB, Xue SA, Chan C, Jordan WJ, Harper JE, Watson MP, Dong R, Ritter MA, Lechler RI, Lombardi G, George AJ
Blood 2005 Nov 1;106(9):2936-43
Blood 2005 Nov 1;106(9):2936-43
Elevated expression of the myc gene in human benign and malignant breast lesions compared to normal tissue.
Spandidos DA, Pintzas A, Kakkanas A, Yiagnisis M, Mahera H, Patra E, Agnantis NJ
Anticancer research 1987 Nov-Dec;7(6):1299-304
Anticancer research 1987 Nov-Dec;7(6):1299-304
No comments: Submit comment
No validations: Submit validation data